Patent · US Active

Inhibitors of EGFR and methods of use thereof

US10836722B2 · kind B2 · utility

1Cited by
0References
18Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 13, 2019
Grant dateNov 17, 2020
Priority date—
Expiry dateJun 13, 2039

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D513/04
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

The disclosure relates to a compound having Formula (I′): and

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.